Armada Hoffler Properties (NYSE:AHH) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $11.00 price target on the stock. This represents a 9.9% upside from the current price of $10.01. |
Albemarle (NYSE:ALB) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $96.00 price target on the stock. This represents a 10.5% upside from the current price of $86.85. |
Applied Digital (NASDAQ:APLD) is now covered by analysts at Compass Point. They set a "buy" rating and a $10.00 price target on the stock. This represents a 47.3% upside from the current price of $6.79. |
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $41.00 price target on the stock. This represents a 147.6% upside from the current price of $16.56. |
Chemours (NYSE:CC) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 39.5% upside from the current price of $19.35. |
Cardiol Therapeutics (NASDAQ:CRDL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock. This represents a 444.3% upside from the current price of $1.29. |
Eledon Pharmaceuticals (NASDAQ:ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock. This represents a 96.9% upside from the current price of $4.57. |
Emerson Electric (NYSE:EMR) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $147.00 price target on the stock. This represents a 15.2% upside from the current price of $127.59. |
Element Solutions (NYSE:ESI) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $28.00 price target on the stock. This represents a 9.9% upside from the current price of $25.47. |
Chesapeake Energy (NASDAQ:EXE) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $96.00 price target on the stock. This represents a 4.9% downside from the current price of $101.00. |
Indivior (NASDAQ:INDV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock. This represents a 30.8% upside from the current price of $12.23. |
INmune Bio (NASDAQ:INMB) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 190.0% upside from the current price of $7.93. |
Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 226.5% upside from the current price of $7.05. |
Minerals Technologies (NYSE:MTX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $103.00 price target on the stock. This represents a 33.1% upside from the current price of $77.38. |
Oklo (NYSE:OKLO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $44.00 price target on the stock. This represents a 39.0% upside from the current price of $31.66. |
Olin (NYSE:OLN) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $38.00 price target on the stock. This represents a 13.3% upside from the current price of $33.54. |
PolyPid (NASDAQ:PYPD) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock. This represents a 315.3% upside from the current price of $3.13. |
Tanger (NYSE:SKT) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $36.00 price target on the stock. This represents a 7.4% upside from the current price of $33.50. |
Talphera (NASDAQ:TLPH) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock. This represents a 448.7% upside from the current price of $0.73. |
Tronox (NYSE:TROX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $17.00 price target on the stock. This represents a 63.7% upside from the current price of $10.39. |
Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $58.00 price target on the stock. This represents a 64.1% upside from the current price of $35.34. |
Westlake (NYSE:WLK) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $168.00 price target on the stock. This represents a 40.7% upside from the current price of $119.44. |
No comments:
Post a Comment
Keep a civil tongue.